Expression of thyroid hormone transporters during critical illness

European Journal of Endocrinology

Volumn 161, Issue 2, 2009, Pages 243-250

  Mebis, Liese ^a   Paletta, Deborah ^a   Debaveye, Yves ^a   Ellger, Björn ^a   Langouche, Lies ^a   D'Hoore, André ^a   Darras, Veerlem ^a   Visser, Theo J ^b   Van Den Berghe, Greet Den ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 10; MONOCARBOXYLATE TRANSPORTER 8; RECOMBINANT HORMONE; RECOMBINANT LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; 3,3',5' TRIIODOTHYRONINE; AMINO ACID TRANSPORTER; MESSENGER RNA; MONOCARBOXYLATE TRANSPORTER; SLC16A10 PROTEIN, HUMAN; SLC16A2 PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DOWN REGULATION; FEMALE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE TRANSPORT; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INTENSIVE CARE; INTERVENTION STUDY; LIOTHYRONINE SYNDROME; LIVER; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SURGICAL STRESS; THYROID DISEASE; ANIMAL; BIOSYNTHESIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE MODEL; EUTHYROID SICK SYNDROME; GENETICS; METABOLISM; MOLECULAR GENETICS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; BASE SEQUENCE; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; EUTHYROID SICK SYNDROMES; FEMALE; HUMANS; LIVER; MALE; MOLECULAR SEQUENCE DATA; MONOCARBOXYLIC ACID TRANSPORTERS; MUSCLE, SKELETAL; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 68349138294     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0290     Document Type: Article

References (47)

1. Docter R, Krenning EP, de Jong M & Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clinical Endocrinology 1993 39 499-518. (Pubitemid 23323946)
2. Wartofsky L & Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocrine Reviews 1982 3 164-217.
3. Van den Berghe G. Dynamic neuroendocrine responses to critical illness. Frontiers in Neuroendocrinology 2002 23 370-391. (Pubitemid 35346212)
4. Van den Berghe G, de Zegher F & Bouillon R. Acute and prolonged critical illness as different neuroendocrine paradigms. Journal of Clinical Endocrinology and Metabolism 1998 83 1827-1834. (Pubitemid 28496301)
5. Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E & Wiersinga WM. Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. Journal of Endocrinology 2004 182 315-323. (Pubitemid 39199015)
6. Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C, Kacskovics I, Larsen PR & Lechan RM. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 2004 145 1649-1655. (Pubitemid 38402371)
7. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F & Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. Journal of Clinical Endocrinology and Metabolism 2001 86 4198-4205. (Pubitemid 32848536)
8. Fliers E, Guldenaar SE, Wiersinga WM & Swaab DF. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1997 82 4032-4036. (Pubitemid 27525507)
9. Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M, Verwaest C, Van der Vorst E, Lauwers P, Bouillon R & Bowers CY. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. Journal of Clinical Endocrinology and Metabolism 1998 83 309-319. (Pubitemid 28496498)
10. Bianco AC, Salvatore D, Gereben B, Berry MJ & Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 2002 23 38-89. (Pubitemid 34185306)
11. Debaveye Y, Ellger B, Mebis L, Van Herck E, CoopmansW, Darras V & Van den Berghe G. Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2. Endocrinology 2005 146 5604-5611. (Pubitemid 41653077)
12. Peeters RP,Wouters PJ, Kaptein E, van Toor H, Visser TJ & Van den Berghe G. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. Journal of Clinical Endocrinology and Metabolism 2003 88 3202-3211. (Pubitemid 36877495)
13. Hennemann G, Krenning EP, Polhuys M, Mol JA, Bernard BF, Visser TJ & Docter R. Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate-limiting in total cellular uptake and metabolism. Endocrinology 1986 119 1870-1872. (Pubitemid 17170565)
14. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 2003 278 40128-40135. (Pubitemid 37248580)
15. Friesema EC, Kuiper GG, Jansen J, Visser TJ & Kester MH. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular Endocrinology 2006 20 2761-2772. (Pubitemid 44833533)
16. Lafreniere RG, Carrel L & Willard HF. A novel transmembrane transporter encoded by the XPCT gene in Xq13.2. Human Molecular Genetics 1994 3 1133-1139. (Pubitemid 24211959)
17. Dumitrescu AM, Liao XH, Weiss RE, Millen K & Refetoff S. Tissuespecific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006 147 4036-4043. (Pubitemid 44268357)
18. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 2007 117 627-635. (Pubitemid 46348521)
19. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 2004 74 168-175. (Pubitemid 38085248)
20. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP & Visser TJ. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004 364 1435-1437. (Pubitemid 39370719)
21. Samson M, Osty J, Francon J & Blondeau JP. Triiodothyronine binding sites in the rat erythrocyte membrane: involvement in triiodothyronine transport and relation to the tryptophan transport system T. Biochimica et Biophysica Acta 1992 1108 91-98.
22. Zhou Y, Samson M, Osty J, Francon J & Blondeau JP. Evidence for a close link between the thyroid hormone transport system and the aromatic amino acid transport system T in erythrocytes. Journal of Biological Chemistry 1990 265 17000-17004. (Pubitemid 20334237)
23. Zhou Y, Samson M, Francon J & Blondeau JP. Thyroid hormone concentrative uptake in rat erythrocytes. Involvement of the tryptophan transport system T in countertransport of triiodothyronine and aromatic amino acids. Biochemical Journal 1992 281 81-86.
24. +/monocarboxylate transporters. Journal of Biological Chemistry 2001 276 17221-17228.
25. Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T & Endou H. The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 2002 79 95-103. (Pubitemid 34112071)
26. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH & Visser TJ. Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10 (MCT10). Molecular Endocrinology 2008 22 1357-1369. (Pubitemid 351786996)
27. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P & Bouillon R. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 2001 345 1359-1367. (Pubitemid 34940724)
28. Weekers F, Van Herck E, Coopmans W, Michalaki M, Bowers CY, Veldhuis JD & Van den Berghe G. A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. Endocrinology 2002 143 764-774. (Pubitemid 34164024)
29. Mebis L, Langouche L, Visser TJ & Van den Berghe G. The type II iodothyronine deiodinase is up-regulated in skeletal muscle during prolonged critical illness. Journal of Clinical Endocrinology and Metabolism 2007 92 3330-3333. (Pubitemid 47236410)
30. van der Geyten S, Van den Eynde I, Segers IB, Kuhn ER & Darras VM. Differential expression of iodothyronine deiodinases in chicken tissues during the last week of embryonic development. General and Comparative Endocrinology 2002 128 65-73.
31. Schatz DL, Sheppard RH, Steiner G, Chandarlapaty CS & de Veber GA. Influence of heparin on serum free thyroxine. Journal of Clinical Endocrinology and Metabolism 1969 29 1015-1022.
32. Morreale de EG, Pastor R, Obregon MJ & Escobar del RF. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 1985 117 1890-1900. (Pubitemid 16200779)
33. Morreale de EG, Calvo R, Escobar del RF & Obregon MJ. Thyroid hormones in tissues from fetal and adult rats. Endocrinology 1994 134 2410-2415. (Pubitemid 24170851)
34. Peeters RP, van der Geyten S,Wouters PJ, Darras VM, van Toor H, Kaptein E, Visser TJ & Van den Berghe G. Tissue thyroid hormone levels in critical illness. Journal of Clinical Endocrinology and Metabolism 2005 90 6498-6507. (Pubitemid 41759305)
35. Roberts LM,Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, MengeshaW, Raman C & Zerangue N. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008 149 6251-6261.
36. Debaveye Y, Ellger B, Mebis L, Visser TJ, Darras VM & Van den Berghe G. Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits. Endocrinology 2008 149 4218-4228.
37. Jansen J, Friesema EC, Milici C & Visser TJ. Thyroid hormone transporters in health and disease. Thyroid 2005 15 757-768. (Pubitemid 41339256)
38. Kaptein EM, Robinson WJ, Grieb DA & Nicoloff JT. Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses. A noncompartmental analysis. Journal of Clinical Investigation 1982 69 526-535.
39. Kaptein EM, Feinstein EI, Nicoloff JT & Massry SG. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. Journal of Clinical Endocrinology and Metabolism 1983 57 181-189.
40. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Reviews 1996 17 45-63. (Pubitemid 26061367)
41. Vanhorebeek I, De Vos R, Mesotten D,Wouters PJ,Wolf-Peeters C & Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005 365 53-59. (Pubitemid 40082146)
42. Bodoky G, Yang ZJ, Meguid MM, Laviano A & Szeverenyi N. Effects of fasting, intermittent feeding, or continuous parenteral nutrition on rat liver and brain energy metabolism as assessed by 31P-NMR. Physiology and Behavior 1995 58 521-527.
43. 3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs. FEBS Letters 1982 140 229-233.
44. Lim CF, Docter R, Visser TJ, Krenning EP, Bernard B, van Toor H, de Jong M & Hennemann G. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids. Journal of Clinical Endocrinology and Metabolism 1993 76 1165-1172. (Pubitemid 23155430)
45. Sarne DH & Refetoff S. Measurement of thyroxine uptake from serum by cultured human hepatocytes as an index of thyroid status: reduced thyroxine uptake from serum of patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1985 61 1046-1052. (Pubitemid 16186700)
46. Vos RA, de Jong M, Bernard BF, Docter R, Krenning EP & Hennemann G. Impaired thyroxine and 3,5,30-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 1995 80 2364-2370.
47. Lim CF, Docter R, Krenning EP, van Toor H, Bernard B, de JongM& Hennemann G. Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects. Clinical Endocrinology 1994 40 79-85. (Pubitemid 24193131)